Lyme Disease: pathogenesis, clinical manifestations, and treatment
DOI:
https://doi.org/10.5281/zenodo.12800162Keywords:
Lyme disease, Borrelia burgdorferi, Clinical manifestations, Antibiotic treatmentAbstract
Lyme disease is a complex infection caused by Borrelia burgdorferi, transmitted by ticks of the genus Ixodes. This study reviews the pathogenesis, clinical manifestations, and treatment of the disease, considering its increasing global prevalence. Transmission occurs mainly in endemic areas such as parts of North America, Europe, and Asia, influenced by the life cycle of ticks and their vertebrate hosts. Integrative research methods were employed to analyze scientific studies available in specialized databases such as MEDLINE.Lyme disease presents a variety of clinical manifestations that evolve through distinct stages: early localized, disseminated, and chronic. Initial symptoms include erythema migrans, followed by systemic manifestations such as arthritis, neurological, and cardiac manifestations. Early diagnosis is challenging due to the nonspecificity of initial symptoms and the limitation of available diagnostic tests. Treatment is based on antibiotic therapy, with an emphasis on early administration to prevent long-term complications. Despite this, a significant percentage of patients develop post-treatment Lyme disease syndrome, characterized by persistent symptoms after adequate treatment. This study highlights the importance of public education for prevention, emphasizing personal protection measures against tick bites and the ongoing development of effective control and treatment strategies to address the challenges posed by Lyme disease."
References
ADKISON, H.; EMBERS, M. E. Lyme disease and the pursuit of a clinical cure. Frontiers in Medicine, v. 10, 24 maio 2023.
ARVIKAR, S. L.; STEERE, A. C. Lyme Arthritis. Infectious Disease Clinics of North America, v. 36, n. 3, p. 563–577, 1 set. 2022.
BAKER, P. J. Is It Possible to Make a Correct Diagnosis of Lyme Disease on Symptoms Alone? Review of Key Issues and Public Health Implications. The American Journal of Medicine, v. 132, n. 10, p. 1148–1152, 1 out. 2019.
BAMM, V. V. et al. Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums. Pathogens, v. 8, n. 4, p. 299–299, 16 dez. 2019.
BOBE, J. et al. Recent Progress in Lyme Disease and Remaining Challenges. Frontiers in Medicine, v. 8, 18 ago. 2021.
BRANDA, J. A.; STEERE, A. C. Laboratory Diagnosis of Lyme Borreliosis. Clinical Microbiology Reviews, v. 34, n. 2, 17 mar. 2021.
COBURN, J. et al. Lyme Disease Pathogenesis. Current Issues in Molecular Biology, p. 473–518, 1 jan. 2022.
DONTA, S. T. What We Know and Don’t Know About Lyme Disease. Frontiers in Public Health, v. 9, 21 jan. 2022.
MAHAJAN, V. Lyme disease: An overview. Indian Dermatology Online Journal, v. 14, n. 5, p. 594–594, 1 jan. 2023.
MAKSIMYAN, S.; SYED, M. S.; VARUN SOTI. Post-Treatment Lyme Disease Syndrome: Need for Diagnosis and Treatment. Cureus, 12 out. 2021.
MARQUES, A. Persistent Symptoms After Treatment of Lyme Disease. Infectious Disease Clinics of North America, v. 36, n. 3, p. 621–638, 1 set. 2022.
MARQUES, A.; FRANC STRLE; WORMSER, G. P. Comparison of Lyme Disease in the United States and Europe. Emerging Infectious Diseases, v. 27, n. 8, p. 2017–2024, 1 ago. 2021.
SCHUTZER, S. E. et al. Direct Diagnostic Tests for Lyme Disease. Clinical Infectious Diseases, v. 68,n. 6, p. 1052–1057, 11 out. 2018.
WINSLOW, C. H.; COBURN, J. Recent discoveries and advancements in research on the Lyme disease spirochete Borrelia burgdorferi. F1000Research, v. 8, p. 763–763, 31 maio 2019.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Social Issues and Health Sciences (JSIHS)
This work is licensed under a Creative Commons Attribution 4.0 International License.